Literature DB >> 19954684

Early administration of enalapril and losartan to patients with type 1 diabetes.

Robert C Stanton.   

Abstract

Entities:  

Year:  2009        PMID： 19954684     DOI： 10.1007/s11892-009-0067-9

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  10 in total

1.  Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Authors:  Wouter B A Eijkelkamp; Zhongxin Zhang; Giuseppe Remuzzi; Hans-Henrik Parving; Mark E Cooper; William F Keane; Shahnaz Shahinfar; Gilbert W Gleim; Matthew R Weir; Barry M Brenner; Dick de Zeeuw
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

Review 2.  Antihypertensive agents for preventing diabetic kidney disease.

Authors:  G F M Strippoli; M Craig; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

3.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

4.  Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysis.

Authors:  Robert A Hamilton; Michael P Kane; Jason Demers
Journal:  Pharmacotherapy       Date:  2003-07       Impact factor: 4.705

5.  Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Authors:  Michael Mauer; Bernard Zinman; Robert Gardiner; Samy Suissa; Alan Sinaiko; Trudy Strand; Keith Drummond; Sandra Donnelly; Paul Goodyer; Marie Claire Gubler; Ronald Klein
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

6.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Authors: 
Journal:  JAMA       Date:  2003-10-22       Impact factor: 56.272

Review 7.  Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?

Authors:  Anastasios N Lasaridis; Panteleimon A Sarafidis
Journal:  Am J Hypertens       Date:  2003-08       Impact factor: 2.689

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  The effects of spironolactone on nephron function in patients with diabetic nephropathy.

Authors:  Ayten Ustundag; Armagan Tugrul; Sedat Ustundag; Necdet Sut; Bora Demirkan
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

Review 10.  Is there a role for direct renin inhibitors in chronic kidney disease?

Authors:  Aldo J Peixoto; Marcelo Orias
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-09       Impact factor: 2.894
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.